These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38655053)

  • 1. LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function.
    Tian X; Hu D; Wang N; Zhang L; Wang X
    Front Genet; 2024; 15():1337525. PubMed ID: 38655053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifies microtubule-binding protein
    Wang W; Zhang J; Wang Y; Xu Y; Zhang S
    Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
    Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
    Front Genet; 2023; 14():1041042. PubMed ID: 36936420
    [No Abstract]   [Full Text] [Related]  

  • 6. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
    Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
    Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermine synthase (
    Pan X; Xue L; Sun Y
    Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.
    Tai P; Wang Z; Chen X; Chen A; Gong L; Cheng Y; Cao K
    Cancer Med; 2023 May; 12(10):11941-11959. PubMed ID: 36205192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights
    Dong X; Jin C; Chen D; Chen Y; Ye ZQ; Zhang X; Huang X; Zhang W; Gu DN
    Front Oncol; 2021; 11():737867. PubMed ID: 34604079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and methylation of
    Zhao Y; Zhao J; Zhong M; Zhang Q; Yan F; Feng Y; Guo Y
    Front Genet; 2022; 13():982241. PubMed ID: 36204311
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrative bioinformatics analysis identifies LINC01614 as a potential prognostic signature in esophageal cancer.
    Yan S; Xu J; Liu B; Ma L; Tan H; Fang C
    Transl Cancer Res; 2021 Apr; 10(4):1804-1812. PubMed ID: 35116503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive landscape of the miRNA-regulated prognostic marker LAYN with immune infiltration and stemness in pan-cancer.
    Jiawen W; Jinfu W; Jianyong L; Yaoguang Z; Jianye W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):10989-11011. PubMed ID: 37335337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer analysis reveals the role of long non-coding RNA LINC01614 as a highly cancer-dependent oncogene and biomarker.
    Wang D; Zhang H; Fang X; Cao D; Liu H
    Oncol Lett; 2020 Aug; 20(2):1383-1399. PubMed ID: 32724381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.
    Hu R; Lu M; She L
    Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer.
    Sun Y; Ling C
    Medicine (Baltimore); 2019 Jul; 98(30):e16437. PubMed ID: 31348244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA LINC01614 is a Diagnostic and Prognostic Marker for Breast Cancer.
    Li W; Cheng Y; Cheng J; Yao J; Song M; Yan M; Qi Y
    Discov Med; 2023 Feb; 35(174):19-27. PubMed ID: 37024438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.